{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:14:44Z","timestamp":1787800484331,"version":"build-2784847793"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:00:00Z","timestamp":1697328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:00:00Z","timestamp":1697328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007525","name":"Universit\u00e9 de Rennes 1","doi-asserted-by":"publisher","award":["D\u00e9fi scientifique"],"award-info":[{"award-number":["D\u00e9fi scientifique"]}],"id":[{"id":"10.13039\/501100007525","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00204-023-03617-x","type":"journal-article","created":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T08:01:40Z","timestamp":1697356900000},"page":"165-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["In silico and in vitro metabolism studies of the new synthetic opiate AP-237 (bucinnazine) using bioinformatics tools"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3848-507X","authenticated-orcid":false,"given":"Romain","family":"Pelletier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Bourdais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Fabresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Jean","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gicquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Le Dar\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,15]]},"reference":[{"issue":"5","key":"3617_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/dta.2550","volume":"11","author":"S Allard","year":"2019","unstructured":"Allard S, Allard P, Morel I, Gicquel T (2019) Application of a molecular networking approach for clinical and forensic toxicology exemplified in three cases involving 3-MeO-PCP, doxylamine, and chlormequat. Drug Test Anal 11(5):669\u2013677","journal-title":"Drug Test Anal"},{"issue":"1","key":"3617_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1124\/dmd.105.006759","volume":"34","author":"C Aninat","year":"2006","unstructured":"Aninat C, Piton A, Glaise D, Le Charpentier T, Langou\u00ebt S, Morel F et al (2006) Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos 34(1):75\u201383","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"3617_CR3","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1248\/cpb.23.1949","volume":"23","author":"S Baba","year":"1975","unstructured":"Baba S, Morishita S (1975) Studies on drug metabolism by use of isotopes. XVI. Species differences in metabolism of 1-butyryl-4-cinnamylpiperazine hydrochloride. Chem Pharm Bull 23(9):1949\u20131954","journal-title":"Chem Pharm Bull"},{"issue":"4","key":"3617_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/dta.2738","volume":"12","author":"P Blanckaert","year":"2020","unstructured":"Blanckaert P, Cannaert A, Van Uytfanghe K, Hulpia F, Deconinck E, Van Calenbergh S et al (2020) Report on a novel emerging class of highly potent benzimidazole NPS opioids: chemical and in vitro functional characterization of isotonitazene. Drug Test Anal 12(4):422\u2013430","journal-title":"Drug Test Anal"},{"key":"3617_CR5","doi-asserted-by":"publisher","unstructured":"Brunetti P, Berardinelli D, Giorgetti A, Schwelm HM, Haschimi B, Pelotti S, et al (2023) Human metabolism and basic pharmacokinetic evaluation of AP\u2010238: a recently emerged acylpiperazine opioid. Drug Test Anal 1\u201315. https:\/\/doi.org\/10.1002\/dta.3535","DOI":"10.1002\/dta.3535"},{"issue":"7","key":"3617_CR6","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00204-022-03289-z","volume":"96","author":"FP Busard\u00f2","year":"2022","unstructured":"Busard\u00f2 FP, Lo Faro AF, Sirignano A, Giorgetti R, Carlier J (2022) In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common \u201cdiuretic and masking agent\u201d in doping. Arch Toxicol 96(7):1989\u20132001","journal-title":"Arch Toxicol"},{"issue":"6","key":"3617_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2174\/138920007781368908","volume":"8","author":"S Caccia","year":"2007","unstructured":"Caccia S (2007) N-dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed. CDM 8(6):612\u2013622","journal-title":"CDM"},{"key":"3617_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123162","volume":"1193","author":"J Carlier","year":"2022","unstructured":"Carlier J, Berardinelli D, Montanari E, Sirignano A, Di Trana A, Busard\u00f2 FP (2022) 3F-\u03b1-pyrrolydinovalerophenone (3F-\u03b1-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS\/MS analysis and targeted\/untargeted data mining. J Chromatogr B 1193:123162","journal-title":"J Chromatogr B"},{"issue":"1","key":"3617_CR9","first-page":"41","volume":"213","author":"RA Carrano","year":"1975","unstructured":"Carrano RA, Kimura KK, McCurdy DH (1975) Analgesic and tolerance studies with AP-237, a new analgesic. Arch Int Pharmacodyn Ther 213(1):41\u201357","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"4","key":"3617_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/hep.21536","volume":"45","author":"V Cerec","year":"2007","unstructured":"Cerec V, Glaise D, Garnier D, Morosan S, Turlin B, Drenou B et al (2007) Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 45(4):957\u2013967","journal-title":"Hepatology"},{"issue":"2","key":"3617_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1021\/acs.chemrestox.0c00224","volume":"34","author":"KC de Bruyn","year":"2021","unstructured":"de Bruyn KC, \u0160\u00edcho M, Mazzolari A, Kirchmair J (2021) GLORYx: Prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics. Chem Res Toxicol 34(2):286\u2013299","journal-title":"Chem Res Toxicol"},{"key":"3617_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2021.122740","volume":"235","author":"A Di Trana","year":"2021","unstructured":"Di Trana A, Brunetti P, Giorgetti R, Marinelli E, Zaami S, Busard\u00f2 FP et al (2021) In silico prediction, LC-HRMS\/MS analysis, and targeted\/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites. Talanta 235:122740","journal-title":"Talanta"},{"issue":"1","key":"3617_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13321-018-0324-5","volume":"11","author":"Y Djoumbou-Feunang","year":"2019","unstructured":"Djoumbou-Feunang Y, Fiamoncini J, Gil-de-la-Fuente A, Greiner R, Manach C, Wishart DS (2019) BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification. J Cheminform 11(1):2","journal-title":"J Cheminform"},{"issue":"4","key":"3617_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41592-019-0344-8","volume":"16","author":"K D\u00fchrkop","year":"2019","unstructured":"D\u00fchrkop K, Fleischauer M, Ludwig M, Aksenov AA, Melnik AV, Meusel M et al (2019) SIRIUS 4: a rapid tool for turning tandem mass spectra into metabolite structure information. Nat Methods 16(4):299\u2013302","journal-title":"Nat Methods"},{"key":"3617_CR15","unstructured":"Experimental study on dependence-producing properties of Qiang Tong Ding (AP-237) (2023) | CiNii Research [Internet]. [cited 2023 May 10]. https:\/\/cir.nii.ac.jp\/crid\/1571417124541832064"},{"issue":"1","key":"3617_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/ijms23010082","volume":"23","author":"PJ Ferron","year":"2021","unstructured":"Ferron PJ, Le Dar\u00e9 B, Bronsard J, Steichen C, Babina E, Pelletier R et al (2021) Molecular networking for drug toxicities studies: the case of hydroxychloroquine in COVID-19 patients. IJMS 23(1):82","journal-title":"IJMS"},{"issue":"6","key":"3617_CR17","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00204-022-03257-7","volume":"96","author":"MF Fogarty","year":"2022","unstructured":"Fogarty MF, Vandeputte MM, Krotulski AJ, Papsun D, Walton SE, Stove CP et al (2022) Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238. Arch Toxicol 96(6):1701\u20131710","journal-title":"Arch Toxicol"},{"key":"3617_CR18","first-page":"dta.3162","volume":"14","author":"T Gicquel","year":"2021","unstructured":"Gicquel T, Pelletier R, Richeval C, Gish A, Hakim F, Ferron P et al (2021) Metabolite elucidation of 2-fluoro-deschloroketamine (2F-DCK) using molecular networking across three complementary in vitro and in vivo models. Drug Test Anal 14:dta.3162","journal-title":"Drug Test Anal"},{"key":"3617_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-1-4939-9420-5_19","volume-title":"Experimental cholestasis research","author":"C Guguen-Guillouzo","year":"2019","unstructured":"Guguen-Guillouzo C, Guillouzo A (2019) Setup and use of HepaRG cells in cholestasis research. In: Vinken M (ed) Experimental cholestasis research. Springer, New York, New York, pp 291\u2013312. https:\/\/doi.org\/10.1007\/978-1-4939-9420-5_19 (Methods in Molecular Biology; vol. 1981)"},{"issue":"1","key":"3617_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","volume":"168","author":"A Guillouzo","year":"2007","unstructured":"Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C (2007) The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem Biol Interact 168(1):66\u201373","journal-title":"Chem Biol Interact"},{"key":"3617_CR21","unstructured":"Hassanien S, Layle N, Holt M, Zhao T, Lula D (2023) 2-methyl AP-237. Cayman NPS metabolism monograph [Internet]. https:\/\/www.caymanchem.com\/product\/26485. Accessed 20 Apr 2023"},{"key":"3617_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/0471250953.bi1324s46","author":"JD Holman","year":"2014","unstructured":"Holman JD, Tabb DL, Mallick P (2014) Employing ProteoWizard to convert raw mass spectrometry data. CP Bioinform [internet]. https:\/\/doi.org\/10.1002\/0471250953.bi1324s46","journal-title":"CP Bioinform [internet]."},{"key":"3617_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2020.104842","volume":"66","author":"C Hugbart","year":"2020","unstructured":"Hugbart C, Verres Y, Le Dar\u00e9 B, Bucher S, V\u00e8ne E, Bodin A et al (2020) Non-oxidative ethanol metabolism in human hepatic cells in vitro: involvement of uridine diphospho-glucuronosyltransferase 1A9 in ethylglucuronide production. Toxicol in Vitro 66:104842","journal-title":"Toxicol in Vitro"},{"key":"3617_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113796","volume":"174","author":"AS Kalgutkar","year":"2020","unstructured":"Kalgutkar AS, Driscoll JP (2020) Is there enough evidence to classify cycloalkyl amine substituents as structural alerts? Biochem Pharmacol 174:113796","journal-title":"Biochem Pharmacol"},{"issue":"21","key":"3617_CR25","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/bioinformatics\/btn323","volume":"24","author":"D Kessner","year":"2008","unstructured":"Kessner D, Chambers M, Burke R, Agus D, Mallick P (2008) ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 24(21):2534\u20132536","journal-title":"Bioinformatics"},{"issue":"6","key":"3617_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrd4581","volume":"14","author":"J Kirchmair","year":"2015","unstructured":"Kirchmair J, G\u00f6ller AH, Lang D, Kunze J, Testa B, Wilson ID et al (2015) Predicting drug metabolism: experiment and\/or computation? Nat Rev Drug Discov 14(6):387\u2013404","journal-title":"Nat Rev Drug Discov"},{"key":"3617_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-019-02062-9","author":"B Le Dar\u00e9","year":"2019","unstructured":"Le Dar\u00e9 B, Allard S, Bouvet R, Baert A, Allard PM, Morel I et al (2019) A case of fatal acebutolol poisoning: an illustration of the potential of molecular networking. Int J Leg Med [internet]. https:\/\/doi.org\/10.1007\/s00414-019-02062-9","journal-title":"Int J Leg Med [internet]"},{"issue":"1","key":"3617_CR28","doi-asserted-by":"publisher","first-page":"19921","DOI":"10.1038\/s41598-020-77106-x","volume":"10","author":"B Le Dar\u00e9","year":"2020","unstructured":"Le Dar\u00e9 B, Ferron PJ, Allard PM, Cl\u00e9ment B, Morel I, Gicquel T (2020) New insights into quetiapine metabolism using molecular networking. Sci Rep 10(1):19921","journal-title":"Sci Rep"},{"key":"3617_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2021.04.006","volume":"346","author":"B Le Dar\u00e9","year":"2021","unstructured":"Le Dar\u00e9 B, Ferron PJ, Couette A, Ribault C, Morel I, Gicquel T (2021) In vivo and in vitro \u03b1-amanitin metabolism studies using molecular networking. Toxicol Lett 346:1\u20136","journal-title":"Toxicol Lett"},{"issue":"47","key":"3617_CR30","doi-asserted-by":"publisher","first-page":"12777","DOI":"10.1039\/D0SC02639E","volume":"11","author":"EE Litsa","year":"2020","unstructured":"Litsa EE, Das P, Kavraki LE (2020) Prediction of drug metabolites using neural machine translation. Chem Sci 11(47):12777\u201312788","journal-title":"Chem Sci"},{"issue":"2","key":"3617_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/biology12020273","volume":"12","author":"AF Lo Faro","year":"2023","unstructured":"Lo Faro AF, Berardinelli D, Cassano T, Dendramis G, Montanari E, Montana A et al (2023) New psychoactive substances intoxications and fatalities during the COVID-19 epidemic. Biology 12(2):273","journal-title":"Biology"},{"issue":"3","key":"3617_CR32","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1016\/j.toxac.2022.06.225","volume":"34","author":"S Malaca","year":"2022","unstructured":"Malaca S, Busard\u00f2 FP, Giorgetti R, Huestis MA, Carlier J (2022) In silico prediction, human hepatocyte metabolism, LC-HRMS\/MS analysis, and targeted\/nontargeted data-mining to characterize 4-acetoxy-N,N-Diisopropyl-Tryptamine Metabolism. Toxicologie Analytique Et Clinique 34(3):S135\u2013S136","journal-title":"Toxicologie Analytique Et Clinique"},{"issue":"2","key":"3617_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11419-018-0413-1","volume":"36","author":"C McKenzie","year":"2018","unstructured":"McKenzie C, Sutcliffe OB, Read KD, Scullion P, Epemolu O, Fletcher D et al (2018) Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users. Forensic Toxicol 36(2):359\u2013374","journal-title":"Forensic Toxicol"},{"issue":"6","key":"3617_CR34","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/jps.2600670606","volume":"67","author":"SI Morishita","year":"1978","unstructured":"Morishita SI, Baba S, Nagase Y (1978) Studies on drug metabolism by use of isotopes XX: ion cluster technique for detection of urinary metabolites of 1-butyryl-4-cinnamylpiperazine by mass chromatography. J Pharm Sci 67(6):757\u2013761","journal-title":"J Pharm Sci"},{"key":"3617_CR35","unstructured":"News (2019) April 2019 \u2013 China: Announcement to place all fentanyl-related substances under national control [Internet]. [cited 2023 May 10]. https:\/\/www.unodc.org\/LSS\/announcement\/Details\/f2adea68-fbed-4292-a4cc-63771c943318. Accessed 10 May 2023"},{"key":"3617_CR36","unstructured":"Observatoire europ\u00e9en des drogues et des toxicomanies (ed) (2020) European drug report: trends and developments. Publications office of the European Union, Luxembourg"},{"issue":"23","key":"3617_CR37","doi-asserted-by":"publisher","first-page":"13900","DOI":"10.1021\/acs.analchem.8b03099","volume":"90","author":"F Olivon","year":"2018","unstructured":"Olivon F, Elie N, Grelier G, Roussi F, Litaudon M, Touboul D (2018) MetGem software for the generation of molecular networks based on the t-SNE algorithm. Anal Chem 90(23):13900\u201313908","journal-title":"Anal Chem"},{"issue":"1","key":"3617_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/15563650.2021.1931693","volume":"60","author":"R Pelletier","year":"2022","unstructured":"Pelletier R, Le Dar\u00e9 B, Grandin L, Couette A, Ferron PJ, Morel I et al (2022a) New psychoactive substance cocktail in an intensive care intoxication case elucidated by molecular networking. Clin Toxicol 60(1):122\u2013125","journal-title":"Clin Toxicol"},{"issue":"12","key":"3617_CR39","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/pharmaceutics14122665","volume":"14","author":"R Pelletier","year":"2022","unstructured":"Pelletier R, Gicquel T, Simoes Eugenio M, Ferron PJ, Morel I, Delehouz\u00e9 C et al (2022b) A Transversal approach combining in silico, in vitro and in vivo models to describe the metabolism of the receptor interacting protein 1 kinase inhibitor sibiriline. Pharmaceutics 14(12):2665","journal-title":"Pharmaceutics"},{"key":"3617_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-022-03427-7","author":"R Pelletier","year":"2022","unstructured":"Pelletier R, Le Dar\u00e9 B, Ferron PJ, Le Bou\u00ebdec D, Kernall\u00e9guen A, Morel I et al (2022c) Use of innovative, cross-disciplinary in vitro, in silico and in vivo approaches to characterize the metabolism of chloro-alpha-pyrrolidinovalerophenone (4-Cl-PVP). Arch Toxicol [internet]. https:\/\/doi.org\/10.1007\/s00204-022-03427-7","journal-title":"Arch Toxicol [internet]."},{"issue":"9","key":"3617_CR41","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3389\/fphar.2018.01145","volume":"11","author":"C P\u00e9rez-Ma\u00f1\u00e1","year":"2018","unstructured":"P\u00e9rez-Ma\u00f1\u00e1 C, Papaseit E, Fonseca F, Farr\u00e9 A, Torrens M, Farr\u00e9 M (2018) Drug interactions with new synthetic opioids. Front Pharmacol 11(9):1145","journal-title":"Front Pharmacol"},{"issue":"5(Special)","key":"3617_CR42","first-page":"2241","volume":"31","author":"Y Ping","year":"2018","unstructured":"Ping Y, Jing C, Qing J (2018) Comparison of the use of different analgesics in the course of anesthesia care based on pharmacoeconomics. Pak J Pharm Sci 31(5(Special)):2241\u20132247","journal-title":"Pak J Pharm Sci"},{"issue":"10","key":"3617_CR43","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1007\/s00204-018-2300-2","volume":"92","author":"N Quesnot","year":"2018","unstructured":"Quesnot N, Bucher S, Gade C, Vlach M, Vene E, Valen\u00e7a S et al (2018) Production of chlorzoxazone glucuronides via cytochrome P4502E1 dependent and independent pathways in human hepatocytes. Arch Toxicol 92(10):3077\u20133091","journal-title":"Arch Toxicol"},{"issue":"19","key":"3617_CR44","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1021\/acschemneuro.1c00522","volume":"12","author":"K Resnik","year":"2021","unstructured":"Resnik K, Brand\u00e3o P, Alves EA (2021) DARK classics in chemical neuroscience: bucinnazine. ACS Chem Neurosci 12(19):3527\u20133534","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"3617_CR45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/cmdc.200700312","volume":"3","author":"L Ridder","year":"2008","unstructured":"Ridder L, Wagener M (2008) SyGMa: combining expert knowledge and empirical scoring in the prediction of metabolites. ChemMedChem 3(5):821\u2013832","journal-title":"ChemMedChem"},{"issue":"3","key":"3617_CR46","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/toxics11030220","volume":"11","author":"S Rojek","year":"2023","unstructured":"Rojek S, Polja\u0144ska E, Chaim W, Maci\u00f3w-G\u0142\u0105b M, Bystrowska B (2023) Metabolic evaluation of synthetic opioids on the example of U-47700 with the use of in vitro and in vivo methods for forensic toxicology application. Toxics 11(3):220","journal-title":"Toxics"},{"key":"3617_CR47","unstructured":"Samano K, Clouette R, Peterson DC (2021) Fatality from 2-methyl AP-237 (2-methyl buccinazine), a novel synthetic opioid drug gaining recreational popularity. In: Proceedings of the 2021 Society of Forensic Toxicologists Annual Meeting"},{"key":"#cr-split#-3617_CR48.1","unstructured":"Schmid R, Heuckeroth S, Korf A, Smirnov A, Myers O, Dyrlund TS, et al (2023) Integrative analysis of multimodal mass spectrometry data in MZmine 3. Nat Biotechnol [Internet]. 2023 Mar 1 [cited 2023 Apr 6]"},{"key":"#cr-split#-3617_CR48.2","unstructured":"https:\/\/www.nature.com\/articles\/s41587-023-01690-2. Accessed 6 Apr 2023"},{"issue":"11","key":"3617_CR49","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"},{"issue":"7","key":"3617_CR50","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","volume":"84","author":"HS Smith","year":"2009","unstructured":"Smith HS (2009) Opioid metabolism. Mayo Clin Proc 84(7):613\u2013624","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"3617_CR51","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/1556-4029.15295","volume":"68","author":"MT Truver","year":"2023","unstructured":"Truver MT, Crosby MM, Gillette AT, Brogan SC, Hoyer JL, Chronister CW et al (2023) Fatal intoxication involving 2-methyl ap -237. J Forensic Sci 68(4):1419\u20131424","journal-title":"J Forensic Sci"},{"key":"3617_CR52","unstructured":"United Nations Office on Drugs and Crime (2021). Drug market trends: cannabis, opioids [Internet]. https:\/\/www.unodc.org\/res\/wdr2021\/field\/WDR21_Booklet_3.pdf. Accessed 5 Apr 2023"},{"key":"3617_CR53","unstructured":"UNODC (2023) Early warning advisory (EWA) on new psychoactive substances (NPS) [Internet]. https:\/\/www.unodc.org\/LSS\/Home\/NPS"},{"issue":"8","key":"3617_CR54","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nbt.3597","volume":"34","author":"M Wang","year":"2016","unstructured":"Wang M, Carver JJ, Phelan VV, Sanchez LM, Garg N, Peng Y et al (2016) Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat Biotechnol 34(8):828\u2013837","journal-title":"Nat Biotechnol"},{"key":"3617_CR55","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3389\/fphar.2019.00826","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Chang X, Luo X, Su M, Xu R, Chen J et al (2019) An integrated approach to characterize intestinal metabolites of four phenylethanoid glycosides and intestinal microbe-mediated antioxidant activity evaluation in vitro using UHPLC-Q-exactive high-resolution mass spectrometry and a 1,1-diphenyl-2-picrylhydrazyl-based assay. Front Pharmacol 10:826","journal-title":"Front Pharmacol"},{"key":"3617_CR56","unstructured":"WHO Expert Commitee on Drug Dependence (2022) Critical review report: 2-Methyl AP-237 [Internet]. https:\/\/cdn.who.int\/media\/docs\/default-source\/controlled-substances\/45th-ecdd\/2-methyl-ap-237_draft.pdf?sfvrsn=768c7c03_1. Accessed 30 Mar 2023"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03617-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-023-03617-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03617-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T02:02:39Z","timestamp":1704247359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-023-03617-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,15]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["3617"],"URL":"https:\/\/doi.org\/10.1007\/s00204-023-03617-x","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,15]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}